This collection of articles, letters, and news releases will define AAPLOG’s position and actions as the Emergency Contraception issue has evolved.

AAPLOG position on “ELLA,” the newest “emergency contraception”

On August 13, 2010, the Food and Drug Administration approved the application for a new “Emergency Contraceptive” drug, ulipristal acetate, under…

AAPLOG testimony to FDA’s Advisory Committee for Reproductive Health Drugs regarding the “emergency contraceptive” ella.

Regarding: Ella, the newly approved, so called, “Emergency Contraceptive” agent AAPLOG testimony on Ulipristal at the FDA hearing Prepared R…

The Latest Word on Emergency Contraception: How Effective is It?

The Most recent Aricles in the Green Journal: What Else Can We Say?? ArticleImpact of Increased Access to EC; Raymond, Et al, Ob & Gyn, Vol. 10…

News Release: FDA Decision on Plan B is Bad Medicine for Women

The FDA’s recent decision to allow over-the-counter status for Plan B “emergency contraception” for women age 18 and over may be superficially appeali…

Letter to the FDA Regarding Over-The-Counter Status For Plan B

Dr. Andrew von Eschenbach, M.D. Acting Commissioner U.S. Food and Drug Administration 5600 Fishers Lane Rockville, MD 20857-0001 Dear Dr. von E…

News Release: Statement on The FDA’s Decision to Delay Action on Over-the-Counter Approval Request for Emergency Contraception

(Holland, MI) The requested Food and Drug Administration (FDA) approval of over-the-counter (OTC) emergency contraception (EC) for women 17 years of a…

News Release: Statement on JAMA Emergency Contraception Study

(Holland, MI) Research released on 5 January 2005 fails to support the contention of those who advocate over-the-counter (OTC) status for the emergenc…